Medicine and Dentistry
Therapeutic Procedure
50%
Disease
50%
Patient
31%
Hematopoietic Stem Cell
31%
Dactinomycin
25%
Gene Therapy
25%
Glycosaminoglycan
25%
Glioblastoma
25%
Stem Cell Gene Therapy
25%
Survival
25%
Enzyme
18%
Diseases
12%
Lysosomal Storage Disease
12%
Ganglioglioma
12%
Cell Line
12%
Neurologic Disease
12%
Enzyme Deficiency
12%
Enzyme Replacement Therapy
12%
Symptom
12%
Bone
12%
High Throughput Screening
9%
Brain
6%
Gene
6%
Enalapril Maleate
6%
In Vitro
6%
Blood Brain Barrier
6%
Hematopoietic Stem Cell Transplantation
6%
Obstetric Delivery
6%
Ex Vivo Gene Transfer
6%
Pediatrics
6%
Somatics
6%
Serositis
6%
Tumor Progression
6%
Stem Cell Transplant
6%
Tumor Spheroid
6%
Arthropathy
6%
Respiratory Disease
6%
Heart Disease
6%
Transplantation
6%
Development
6%
Lifespan
6%
Monocyte
6%
Nervous System Physiology
6%
Lysosome Enzyme
6%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Lysozyme
43%
Hematopoietic Stem Cell
37%
Mucopolysaccharidosis
25%
Lentivirus Vector
25%
Glycosaminoglycan
25%
Survival
25%
Electric Potential
21%
Lysosomal Storage Disease
18%
Nested Gene
12%
Biodistribution
12%
Blood Brain Barrier
12%
High Throughput Screening
9%
Transfer Gene
6%
Cryopreservation
6%
Multicellular Spheroid
6%
Germline
6%
Cell Viability
6%
NOD SCID Gamma Mouse
6%
Mouse Model
6%
Adulthood
6%
Therapeutic Protein
6%
Hematopoietic Stem Cell Transplantation
6%
Scale up
6%
Ex Vivo Gene Transfer
6%
Pharmacodynamics
6%
Dose
6%
Monocyte
6%
Development
6%
Lifespan
6%
Glycosaminoglycan
6%
Pediatrics
6%
Human Cell
6%
Genome Editing
6%
Hematopoietic Stem Cell Transplantation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Enalapril Maleate
31%
Diseases
25%
Dactinomycin
25%
Mucopolysaccharidosis
25%
Lentivirus Vector
25%
Glycosaminoglycan
25%
Glioblastoma
25%
Survival
25%
Genotoxicity
12%
Neurologic Disease
12%
Lysosome Storage Disease
12%
Biodistribution
12%
Glioma
12%
Western Blot
12%
Symptom
12%
Enzyme
12%
Clinical Trial
12%
High-Throughput Screening
9%
Protein
6%
Enzyme Deficiency
6%
NOD SCID Gamma Mouse
6%
Blood-Brain Barrier
6%
Mouse Model
6%
Deterioration
6%
Tumor Growth
6%
Death
6%
Arthropathy
6%
Inflammation
6%
Respiratory Tract Disease
6%
Dose Limit
6%
Heart Disease
6%
Pharmacodynamics
6%
Replacement Therapy
6%
